Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Fibrinogen Concentrate in Isolated Traumatic Brain Injury and the Effect on Post Bleeding & Complications

NCT03304899 is registered in ClinicalTrials.gov with Leila Dehghani as lead sponsor.

NCT NCT03304899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03304899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Fibrinogen Concentrate in Isolated Traumatic Brain Injury and the Effect on Post Bleeding & Complications
Lead sponsor
Leila Dehghani
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 23, 2018
Completion date
January 21, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, traumatic brain injury